The Bayh-Dole Act: Spurring American Biopharmaceutical Innovation

A teaser image of PhRMA's fact sheet on the Bayh-Doyle Act, updated for October 2022

Congress passed the Bayh-Dole Act in 1980 with strong bipartisan support, creating a framework where researchers receiving federal funds could patent their inventions and license them to private companies so they could continue to research and develop them into products that benefit the public. This landmark legislation ensures that innovative ideas are protected and brought to market. It has contributed nearly $2 trillion to the U.S. economy and supported 6.5 million jobs.

A teaser image of PhRMA's fact sheet on the Bayh-Doyle Act, updated for October 2022

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.